Purpose: e purpose of this study was to analyze the e ects of estrogen de ciency and hormone replacement therapy (HRT) on brinolytic activity in a rat mode of surgicallyinduced menopause.Methods: Twelve-week-old, sexually mature female Sprague-Dawley rats, each weighing 200-250 g, were randomly divided into four groups: (1) sham-operated group, (2) ovariectomy group, (3) ovariectomy group followed by oral administration of daily 17β-estradiol (0.02 mg/kg/day) (E2) + norethisterone acetate (0.01 mg/kg/day), and (4) ovariectomy group followed by oral administration of daily 17β-estradiol (0.01 mg/kg/ day) + drospirenone (0.02 mg/kg/day). Tissue plasminogen activator (tPA) antigen, plasminogen activator inhibitor-1 (PAI-1) antigen, and PAI-1/tPA levels were measured as markers of brinolysis in plasma and liver and brain tissue.Results: Compared with sham-operated rats, ovariectomized rats showed higher levels of brinolytic activity; however, the increased brinolytic activity in plasma and liver tissue was signi cantly reduced by HRT regimens. No change was observed in the levels of brinolytic activity in brain tissue.Conclusions: HRT showed bene cial e ects by decreasing brinolytic activity related to surgically-induced menopause. Short-term HRT treatment was associated with a shi in the procoagulant-anticoagulant balance toward a procoagulant state.